Vaccination willingness in association with personality traits in patients with multiple sclerosis in the course of SARS-CoV-2 pandemic.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
07 09 2022
07 09 2022
Historique:
received:
22
12
2021
accepted:
22
08
2022
entrez:
7
9
2022
pubmed:
8
9
2022
medline:
11
9
2022
Statut:
epublish
Résumé
Vaccination is a key strategy for controlling the SARS-CoV-2 pandemic. Acceptance of SARS-CoV-2 vaccines by chronically ill patients, such as multiple sclerosis (MS) patients, plays an important role in prevention of complicated disease course. This longitudinal, prospective, multi-centre-study of German MS-patients aimed to detect socio-demographic, clinical, or psychological determinants of attitudes towards standard vaccines, SARS-CoV-2 vaccines, and governmental measures before/during the pandemic. Exactly 404 MS-patients were investigated by standardized questionnaires and structured interviews on socio-demographic, clinical-neurological, and psychological characteristics, vaccination status, and vaccination from June 2019. Data on SARS-CoV-2 vaccination willingness were collected in two follow-up assessments (1st: June to July 2020, before SARS-CoV-2 vaccine availability, N = 200; 2nd: March to May 2021, after SARS-CoV-2 vaccine availability, N = 157). Age, sex, MS course type, depression, and personality characteristics (Extraversion, Novelty seeking, Self-directedness, and Cooperativeness) were significantly associated with vaccination willingness. Although the majority of MS-patients showed SARS-CoV-2 vaccination willingness at both follow-ups (1st: 60%, 2nd: 61%), a substantial proportion had concerns and were undecided or opposed to vaccination. Socio-demographic variables like age and sex, psychopathological status, and various personality characteristics might influence vaccination willingness and should be considered when discussing with MS-patients about SARS-CoV-2 vaccination.
Identifiants
pubmed: 36071083
doi: 10.1038/s41598-022-18912-3
pii: 10.1038/s41598-022-18912-3
pmc: PMC9449937
doi:
Substances chimiques
Antibodies, Viral
0
COVID-19 Vaccines
0
Viral Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
15147Informations de copyright
© 2022. The Author(s).
Références
Lancet Infect Dis. 2022 Feb;22(2):183-195
pubmed: 34756186
Lancet. 2018 Apr 21;391(10130):1622-1636
pubmed: 29576504
Lancet Neurol. 2018 Feb;17(2):162-173
pubmed: 29275977
Clin Infect Dis. 2020 Jul 28;71(15):703-705
pubmed: 32282038
Front Psychol. 2020 Oct 19;11:575950
pubmed: 33192883
Arch Gen Psychiatry. 1993 Dec;50(12):975-90
pubmed: 8250684
J Med Life. 2021 Mar-Apr;14(2):225-237
pubmed: 34104246
Autoimmun Rev. 2017 Sep;16(9):925-936
pubmed: 28698092
J Neurol Neurosurg Psychiatry. 2021 Oct;92(10):1033-1043
pubmed: 34353858
Front Mol Biosci. 2021 Mar 25;8:635245
pubmed: 33869282
Int J Soc Psychiatry. 2020 Aug;66(5):504-511
pubmed: 32380879
BMJ. 2021 Sep 15;374:n2211
pubmed: 34526310
Vaccine. 2020 Nov 17;38(49):7789-7798
pubmed: 33109389
Science. 2021 Jul 9;373(6551):147
pubmed: 34244391
Nat Rev Dis Primers. 2018 Nov 8;4(1):43
pubmed: 30410033
BMJ. 2021 Mar 11;372:n699
pubmed: 33707182
Science. 2021 Jul 30;373(6554):479
pubmed: 34326217
Age Ageing. 2021 Feb 26;50(2):279-283
pubmed: 33320183
Ann Intern Med. 2020 Dec 15;173(12):964-973
pubmed: 32886525
Arq Neuropsiquiatr. 2015 Mar;73(3):200-4
pubmed: 25807124
J Intern Med. 2015 Oct;278(4):369-95
pubmed: 26212387
Mult Scler. 2019 Oct;25(12):1641-1652
pubmed: 30230952
Eur Neurol. 2022;85(2):104-111
pubmed: 34743082
Vaccine. 2020 Sep 29;38(42):6500-6507
pubmed: 32863069
Assessment. 2011 Mar;18(1):39-49
pubmed: 20484711
Curr Opin Neurol. 2020 Jun;33(3):286-294
pubmed: 32374570
Isr J Health Policy Res. 2021 Mar 19;10(1):26
pubmed: 33741063
Int Immunopharmacol. 2021 Aug;97:107724
pubmed: 33951558
Mult Scler Relat Disord. 2020 Jun;41:102164
pubmed: 32388452
Mult Scler Relat Disord. 2020 Nov;46:102512
pubmed: 32977074
Neurology. 1983 Nov;33(11):1444-52
pubmed: 6685237
Nat Rev Neurol. 2022 May;18(5):289-306
pubmed: 35388213
Lancet Psychiatry. 2020 Jun;7(6):547-560
pubmed: 32304649
J Gen Intern Med. 2020 Aug;35(8):2296-2303
pubmed: 32472486
Mult Scler Relat Disord. 2021 Jun;51:102880
pubmed: 33740481
J Neurol. 2021 May;268(5):1598-1607
pubmed: 32813051
Front Psychol. 2020 Jun 18;11:1491
pubmed: 32625157
Cardiovasc Pathol. 2021 Jan - Feb;50:107278
pubmed: 32889088
Mult Scler Relat Disord. 2021 Apr;49:102788
pubmed: 33508570
JAMA Netw Open. 2020 Oct 1;3(10):e2025594
pubmed: 33079199
PLoS One. 2021 May 10;16(5):e0248372
pubmed: 33970933
Front Immunol. 2019 Aug 07;10:1883
pubmed: 31440255
Acta Psychiatr Scand. 2003 Mar;107(3):216-21
pubmed: 12580829
EBioMedicine. 2020 Jun;56:102822
pubmed: 32535547
Int J Environ Res Public Health. 2021 Jul 22;18(15):
pubmed: 34360063
Eur J Health Econ. 2020 Sep;21(7):977-982
pubmed: 32591957
Mult Scler J Exp Transl Clin. 2021 May 31;7(2):20552173211017159
pubmed: 34104472
Br J Psychiatry. 2002 Aug;181:158-62
pubmed: 12151288
Nat Rev Neurol. 2016 Apr;12(4):217-33
pubmed: 26943779
Autoimmun Rev. 2016 Mar;15(3):210-20
pubmed: 26589194
N Engl J Med. 2018 Jan 11;378(2):169-180
pubmed: 29320652
BMJ. 2021 Nov 2;375:n2635
pubmed: 34728500